These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 2099324)

  • 1. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects.
    Ceriello A
    Diabetologia; 1993 Nov; 36(11):1119-25. PubMed ID: 8270125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetes.
    Hara T; Uemoto R; Sekine A; Mitsui Y; Masuda S; Kurahashi K; Yoshida S; Otoda T; Yuasa T; Kuroda A; Ikeda Y; Endo I; Honda S; Yoshimoto K; Kondo A; Tamaki T; Matsumoto T; Matsuhisa M; Abe M; Aihara KI
    J Diabetes Investig; 2021 Dec; 12(12):2172-2182. PubMed ID: 34043882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin cofactor II in diabetic patients.
    Duboscq C; Quintana I; Barros J; Kordich L
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):201-4. PubMed ID: 8054451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein C deficiency in insulin-dependent diabetes: a hyperglycemia-related phenomenon.
    Ceriello A; Quatraro A; Dello Russo P; Marchi E; Barbanti M; Milani MR; Giugliano D
    Thromb Haemost; 1990 Aug; 64(1):104-7. PubMed ID: 2274914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low plasma heparin cofactor II levels in thalassaemia syndromes are corrected by chronic blood transfusion.
    O'Driscoll A; Mackie IJ; Porter JB; Machin SJ
    Br J Haematol; 1995 May; 90(1):65-70. PubMed ID: 7786797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamic changes and localization of plasma heparin cofactor II before and after delivery in hypertensive pregnancy].
    Chen X; Zhang G; Wang C
    Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):468-70. PubMed ID: 11721410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a reduced heparin cofactor II biological activity in diabetes.
    Ceriello A; Quatraro A; Dello Russo P; Marchi E; Milani MR; Giugliano D
    Haemostasis; 1990; 20(6):357-61. PubMed ID: 2099324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein C inhibitor (PCI) and heparin cofactor II (HCII): possible alternative roles of these heparin-binding serpins outside the hemostatic system.
    Geiger M; Krebs M; Jerabek I; Binder BR
    Immunopharmacology; 1997 Jun; 36(2-3):279-84. PubMed ID: 9228558
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin cofactor II modulates the response to vascular injury.
    Tollefsen DM
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):454-60. PubMed ID: 17194895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role].
    Rossi EB; Duboscq CL; Kordich LC
    Medicina (B Aires); 1999; 59(1):95-104. PubMed ID: 10349131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin cofactor II: discovery, properties, and role in controlling vascular homeostasis.
    Rau JC; Mitchell JW; Fortenberry YM; Church FC
    Semin Thromb Hemost; 2011 Jun; 37(4):339-48. PubMed ID: 21805439
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.